Research shows why second coronavirus vaccine dose is important

The study showed that the number of antibodies produced and protection offered by vaccination increased substantially after the second vaccine dose was given

covaxin, bharat biotech, coronavirus vaccine, covid-19, vaccination
IANS New York
2 min read Last Updated : Jul 10 2021 | 5:59 PM IST

A new study of antibodies produced in saliva after Pfizer-BioNTech Covid-19 vaccine shows both importance of second vaccine dose and updating vaccines to combat new variants of concern.

The study showed that the number of antibodies produced and protection offered by vaccination increased substantially after the second vaccine dose was given, showing the importance of receiving the second dose.

The team, including Nicole Schneiderhan-Marra at the University of Tubingen, also examined whether it offered protection against Alpha and Beta variants.

They found that while there was no reduction in neutralising antibodies against the Alpha variant, there was a substantial reduction in neutralising antibodies against the Beta variant, indicated the study, presented at the European Congress of Clinical Microbiology & Infectious Diseases.

To see how the protection offered by the vaccine changed for different variants, the team firstly profiled the antibodies generated by vaccination and then examined their neutralising capacity.

In addition to antibodies circulating within the blood, they checked for the presence of antibodies in saliva as a "first line of defence".

To do this, they adapted a previously developed assay that measures the antibodies present against SARS-CoV-2 and other coronaviruses in the blood, to include targets from variants of concern and to look specifically at the neutralising antibodies.

They collected samples from 23 vaccinated individuals (age 26-58 years, 22 per cent female) who had been vaccinated with the Pfizer-BioNTech vaccine after the first and second doses.

For control groups, the team also collected samples from 35 infected blood donors, 27 infected saliva donors and 49 non-infected saliva donors and also control samples of blood and saliva sourced commercially from before the pandemic began from different age groups.

When looking at the saliva, they saw that vaccinated individuals had large amounts of antibodies present compared to infected individuals, suggesting that vaccination not only offers protection against becoming infected but should you become infected, it reduces the possibility of you transmitting it to others.

--IANS

vc/pgh

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jul 10 2021 | 5:58 PM IST

Next Story